Behind the Scenes of the Spanish Biotech Industry’s Boom
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in…
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in…
Rare genetic diseases in the central nervous system may be less of a headache in…
Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for…
Minoryx Therapeutics has dosed the first patient in its Phase II/III trial for patients with adrenomyeloneuropathy,…
I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in…
Minoryx Therapeutics has successfully completed a Phase I trial for its lead compound MIN-102 targeting X-linked adrenoleukodystrophy…
We've compiled a list of some of the latest advances of biotech in the field…
As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from…
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts…